Current status of intra-cranial stereotactic radiotherapy and stereotactic radiosurgery in Australia and New Zealand: key considerations from a workshop and surveys.
Australia
New Zealand
Stereotactic radiosurgery
Stereotactic radiotherapy
Survey
Journal
Physical and engineering sciences in medicine
ISSN: 2662-4737
Titre abrégé: Phys Eng Sci Med
Pays: Switzerland
ID NLM: 101760671
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
30
09
2021
accepted:
20
01
2022
pubmed:
4
2
2022
medline:
11
3
2022
entrez:
3
2
2022
Statut:
ppublish
Résumé
Recently, there has been increased interest worldwide in the use of conventional linear accelerator (linac)-based systems for delivery of stereotactic radiosurgery/radiotherapy (SRS/SRT) contrasting with historical delivery in specialised clinics with dedicated equipment. In order to gain an understanding and define the current status of SRS/SRT delivery in Australia and New Zealand (ANZ) we conducted surveys and provided a single-day workshop. Prior to the workshop ANZ medical physicists were invited to complete two surveys: a departmental survey regarding SRS/SRT practises and equipment; and an individual survey regarding opinions on current and future SRS/SRT practices. At the workshop conclusion, attendees completed a second opinion-based survey. Workshop discussion and survey data were utilised to identify areas of consensus, and areas where a community consensus was unclear. The workshop was held on the 8th Sept 2020 virtually due to pandemic-related travel restrictions and was attended by 238 radiation oncology medical physicists from 39 departments. The departmental survey received 32 responses; a further 89 and 142 responses were received to the pre-workshop and post-workshop surveys respectively. Workshop discussion indicated a consensus that for a department to offer an SRS/SRT service, a minimum case load should be considered depending on availability of training, peer-review, resources and equipment. It was suggested this service may be limited to brain metastases only, with less common indications reserved for departments with comprehensive SRS/SRT programs. Whilst most centres showed consensus with treatment delivery techniques and image guidance, opinions varied on the minimum target diameter and treatment margin that should be applied.
Identifiants
pubmed: 35113342
doi: 10.1007/s13246-022-01108-4
pii: 10.1007/s13246-022-01108-4
pmc: PMC8901507
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
251-259Informations de copyright
© 2022. The Author(s).
Références
J Appl Clin Med Phys. 2016 Sep 08;17(5):184-199
pubmed: 27685124
BMC Cancer. 2016 Aug 19;16(1):659
pubmed: 27542716
Acta Oncol. 2019 Sep;58(9):1275-1282
pubmed: 31257960
Radiother Oncol. 2020 Jun;147:136-143
pubmed: 32294607
Med Phys. 2005 Jul;32(7Part1):2380-2398
pubmed: 28493584
Br J Neurosurg. 2002 Oct;16(5):477-82
pubmed: 12498492
J Med Imaging Radiat Oncol. 2015 Oct;59(5):646-53
pubmed: 26122017
J Clin Neurosci. 2017 Nov;45:48-53
pubmed: 28866073
World Neurosurg. 2020 Dec;144:e797-e806
pubmed: 32971279
Med Phys. 2008 Sep;35(9):4262-77
pubmed: 18841876
J Neurosurg. 2018 Apr 20;130(3):797-803
pubmed: 29676690
World Neurosurg. 2019 Feb;122:e1557-e1561
pubmed: 30471438
Br J Radiol. 2014 May;87(1037):20130681
pubmed: 24620840
J Neurosurg. 2016 Apr;124(4):1018-24
pubmed: 26473783
Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):100-8
pubmed: 25442342
Expert Rev Anticancer Ther. 2018 Sep;18(9):887-900
pubmed: 29940802
J Med Phys. 2021 Jan-Mar;46(1):16-25
pubmed: 34267485
Cancer. 2011 Oct 1;117(19):4566-72
pubmed: 21412761
J Natl Compr Canc Netw. 2017 Dec;15(12):1494-1502
pubmed: 29223987
J Neurosurg. 2018 Dec 21;131(6):1848-1854
pubmed: 30579284
Radiat Oncol. 2018 Mar 5;13(1):38
pubmed: 29506539
Br J Radiol. 2013 Sep;86(1029):20130331
pubmed: 23873906
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):540-6
pubmed: 26460996
J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):797-803
pubmed: 6352865
Expert Rev Anticancer Ther. 2016 Jul;16(7):731-40
pubmed: 27186849
Radiother Oncol. 2017 Jul;124(1):11-17
pubmed: 28687397
J Appl Clin Med Phys. 2017 Sep;18(5):10-21
pubmed: 28786239
Med J Aust. 2020 Jun;212(11):526-527
pubmed: 32249431
J Appl Clin Med Phys. 2018 Mar;19(2):111-120
pubmed: 29363282
BJR Open. 2019 Jul 19;1(1):20190022
pubmed: 33178949
Clin Oncol (R Coll Radiol). 2012 Nov;24(9):629-39
pubmed: 22633542
Phys Eng Sci Med. 2020 Jun;43(2):641-650
pubmed: 32524446
J Appl Clin Med Phys. 2018 Nov;19(6):99-108
pubmed: 30221462
J Med Imaging Radiat Oncol. 2019 Oct;63(5):711-720
pubmed: 31464070